Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


More German Companies Get To Work On COVID-19 Diagnostic Test Development

Executive Summary

Another three in vitro diagnostics companies in Germany are working on tests for the early detection of COVID-19, with confirmed infections reaching 89,000 globally by 2 March.

You may also be interested in...

COVID-19 Fact File: Global Diagnostic Test Pipeline

Medtech Insight is tracking the IVD companies manufacturing tests for SARS-CoV-2, the coronavirus that causes COVID-19.

NeuMoDx Molecular Launches Coronavirus Test

NeuMoDx Molecular announced plans to develop a coronavirus test for its own high-throughput molecular diagnostics platform.

LabCorp Launches COVID-19 Testing, Quest Diagnostics Will Provide Testing Starting 9 March In US

LabCorp and Quest announced they will offer testing to detect COVID-19 to address the public health crisis.

Related Content


Related Companies

Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts